Secondary Logo

Share this article on:

Leveling-off of declining trend of cardiovascular disease-related mortality in the USA: the challenge to rein in obesity and diabetes epidemic

Zia, Aishaa,b; Siddiqui, Hafiz, U.b; Mohiuddin, Hafsaa; Gul, Sajjadc

Cardiovascular Endocrinology & Metabolism: June 2018 - Volume 7 - Issue 2 - p 54–55
doi: 10.1097/XCE.0000000000000146
Viewpoint

aDow Medical College, Dow University of Health Sciences, Karachi, Pakistan

bDepartment of Thoracic and Cardiovascular Surgery, Heart and Vascular Institute

cInternal Medicine Department, Fairview Hospital, Cleveland Clinic, Cleveland, Ohio, USA

Correspondence to Hafiz U. Siddiqui, MD, Department of Thoracic and Cardiovascular Surgery, Heart and Vascular Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, USA Tel: +1 516 666 7169; e-mails: siddiqh@ccf.org, umairsiddiqui200@hotmail.com

Received September 14, 2017

Accepted November 10, 2017

Although cardiovascular disease (CVD) has remained the number one cause of death in the USA since 1921, the morbidity and mortality related to CVD has markedly declined over the last five decades, representing one of the greatest public health achievements of the last century. The two major reasons of this reduction have been advances in the treatment of CVD and more aggressive control of modifiable risk factors 1. However, this year’s American Heart Association Heart Disease and Stroke Statistics are sobering, as the CVD-related mortality rates, which had progressively been declining, show clear evidence of leveling off 2. This is likely related to the growing epidemic of obesity and diabetes, which, left unabated, poses a tremendous threat to what has been achieved (Figs 1 and 2).

Fig. 1

Fig. 1

Fig. 2

Fig. 2

While several modifiable CVD risk factors, including smoking, hypertension, elevated serum cholesterol, and physical inactivity, appear to have temporally decreased, obesity and diabetes have significantly increased. Using a wide array of US data, Ford et al. 1 explained the decline in coronary disease-related mortality from 1980 to 2000 through reduction in CVD risk factors and increased use of evidence-based medical therapies, though in their analysis increases in BMI and prevalence of diabetes appeared to offset some of this benefit. Fox et al. 5 also showed that the proportion of CVD attributable to diabetes has increased over the 50 years (1952–1998) in Framingham Heart Study.

Currently, 30.3 million people (9.4% of US population) have diabetes. Moreover, nearly 33.9% (84.1 million) of US adults of 18 years or older have ‘prediabetes’, a condition which places them at an increased risk of developing diabetes and CVD 3. It has been projected that by 2050, over 25% of the US adult population will be diabetic 6.

Increasing body mass is undoubtedly the primary driver of diabetes. According to recent Center of Disease Control and Prevention data, 29.6% of adults aged 18 years and older in 2016 were obese 4. It is projected that by 2030 obesity will contribute to six million new cases of diabetes and five million new cases of coronary heart disease and stroke 7. Rises in obesity and diabetes are not only a threat to cardiovascular health but also carry a huge economic impact. The total cost of diagnosed diabetes in the USA in 2012 was $245 billion, an increase of 41% from 2007 8; and this is projected to increase further (by >100%) to $514 billion by 2025, an expenditure comparable to the total Medicare budget 9. A great share of this money will be spent managing CVD complications.

The good news is that much of obesity and diabetes appears preventable through education and simple life-style modifications. Interventions such as regular exercise and a healthy diet leading to weight-loss have proven effective in the prevention and management of diabetes 10. Unfortunately, data suggest that many of these favorable behaviors are not regularly practiced. This makes it imperative to identify the factors hindering the application of obesity and diabetes prevention programs and address them accordingly.

Efforts to control the health and cost-related consequences of diabetes should target at least two large groups of patients. First, in people with diagnosed diabetes, appropriate blood glucose management through diet, regular exercise, and appropriate medications is essential to prevent microvascular and macrovascular complications such as CVD. Appropriate education and close surveillance is critical in this endeavor. Second, early identification of patients with prediabetes, many of whom are currently unrecognized, is extremely important. Life-style interventions should be emphasized to these patients to prevent them from progressing to diabetes. Insurance coverage and easy access to exercise programs and dietary counseling can prove extremely cost-effective in the long-term.

Back to Top | Article Outline

Acknowledgements

Conflicts of interest

There are no conflicts of interest.

Back to Top | Article Outline

References

1. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980–2000. N Engl J Med 2007; 356:2388–2398.
2. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R. On behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics – 2017 update: a report from the American Heart Association. Circulation 2017; 135:e146–e603.
3. Centers for Disease Control and Prevention. National diabetes statistics report, 2017. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2017.
4. Centers for Disease Control and Prevention. National Center for Chronic Disease Prevention and Health Promotion. Nutrition, physical activity, and obesity: data, trend and maps. Available at: https://www.cdc.gov/nccdphp/dnpao/data-trends-maps/index.html. [Accessed 5 November 2017].
5. Fox CS, Coady S, Sorlie PD, D’Agostino RB Sr, Pencina MJ, Vasan RS, et al. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation 2007; 115:1544–1550.
6. Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr 2010; 8:29.
7. Trust for America’s Health. Adult obesity rates could exceed 60 percent in 13 U.S. states by 2030, according to new study. ScienceDaily 2012. Available at: http://www.sciencedaily.com/releases/2012/09/120918190923.htm. [Accessed 5 November 2017].
8. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care 2013; 36:4 1033–1046.
9. Rowley WR, Bezold C. Creating public awareness: state 2025 diabetes forecasts. Popul Health Manag 2012; 15:194–200.
10. Klein S, Sheard NF, Pi-Sunyer X, Daly A, Wylie-Rosett J, Kulkarni K, Clark NG. American Diabetes Association; North American Association for the Study of Obesity; American Society for Clinical Nutrition. Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies. A statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition. Am J Clin Nutr 2004; 80:257–263.
© 2018Wolters Kluwer Health Lippincott Williams Wilkins